CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Skin Cancer

 

Role for PTEN in DNA Damage Removal and Prevention of Non-Melanoma Skin Cancer

By Anna Azvolinsky, PhD | July 28, 2011

Using in vitro techniques and mouse models, scientists at the University of Chicago Department of Medicine and colleagues have demonstrated that downregulation of PTEN in epidermal keratinocytes predisposes skin to ultraviolet B (UVB)-induced tumorigenesis. PTEN was first identified in 1997 and is known to prevent genomic instability and promote cellular repair preventing neoplastic growth and tumor progression.

The findings support the essential role of PTEN in skin tumor supporesion via its function in the removal of DNA damage caused by UVB radiation. The research paper was published on July 26, 2011 in Cancer Research (doi: 10.1158/0008-5472.CAN-10-4614)). 

Skin cancer is the most common type of cancer in the United States, with non-melanoma cancer accounting for 96% of all skin malignancies. More than 1 million new cases of skin cancer are diagnosed each year. These patients account for 40% of annual newly diagnosed cancers. This number is continuosly rising due to both more cases as well as more public awareness, which increases the number of diagnoses. The biggest skin cancer risk factor is UVB radiation from sunlight. 

Yu-Ying He, Ph.D., an assistant professor of medicine at the University of Chicago, along with colleagues at other institutions, created mice with only one copy of the PTEN gene and found that the reduced levels of PTEN resulted in a higher probability of the mice developing UVB-induced skin cancers. 

“This was an unexpected finding and definitely provides a new approach for chemoprevention strategies,” she said. “It’s possible that if we can increase PTEN activity through nutritional supplements or some sort of pharmaceutical intervention, we may be able to prevent this common cancer, stated professor He. 

To demonstrate the role of PTEN in the development of human skin cancers, the researchers analyzed skin samples from normal, premalignant lesions as well as invasive squamous cell
carcinoma (SCC) samples. PTEN levels were found to be reduced in 92% of premalignant lesions (23 of 25) and 94% of invasive SCC lesions (26 of 28) compared to normal skin samples (0 of 16). 

The study also demonstrated that PTEN is essential for repair of UVB-induced DNA damage in human keratinocytes and that its downregulation delayed exit from growth arrest after irradiation.
The experiments show that PTEN positively regulates global genomic nucleotide excision repair in keratinocytes. When the skin cells were exposed to UVB radiation, the cells that had lower PTEN levels had slower DNA repair because of the loss of a key DNA repair protein, xeroderma pigmentosum C (XPC). When the researchers restored the levels of XPC, DNA repair was also partly restored. 

“Cells without appropriate levels of PTEN were not able to repair sufficiently,” said He. Professor He’s laboratory plans to evaluate thechemopreventive potential of restoring PTEN function as a follow-up to these results.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Skin Cancer
Evidence on Skin Cancer
Guidelines on Skin Cancer
Patient Education on Skin Cancer
Clinical Trials on Skin Cancer
Practical Articles on Skin Cancer
Research and Reviews on Skin Cancer
All "Skin Cancer" results

CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy